Key result
Renal sympathetic denervation reduced 24-hour systolic blood pressure variability (SDsys) by 20.1% at 6 months in patients with therapy-refractory arterial hypertension.
Why the study?
Does catheter-based bilateral renal sympathetic denervation reduce 24-hour blood pressure variability in patients with therapy-refractory arterial hypertension?
Observational (n=11)
Open-label
No
Does catheter-based bilateral renal sympathetic denervation reduce 24-hour blood pressure variability in patients with therapy-refractory arterial hypertension?
Renal sympathetic denervation significantly reduces 24-hour blood pressure variability in patients with therapy-refractory hypertension, independent of its effects on mean blood pressure levels.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in refractory hypertension; hypothesis-generating for BP variability reduction and requires randomized confirmation.
BACKGROUND: In patients with arterial hypertension, increased blood pressure (BP) variability contributes to end organ damage independently from mean levels of arterial BP. Increased BP variability has been linked to alterations in autonomic function including sympathetic overdrive. We hypothesized that catheter-based renal sympathetic denervation (RDN) confers beneficial effects on BP variability. METHODS AND RESULTS: Eleven consecutive patients with therapy-refractory arterial hypertension (age 68.9 ± 7.0 years; baseline systolic BP 189 ± 23 mmHg despite medication with 5.6 ± 2.1 antihypertensive drugs) underwent bilateral RDN. Twenty-four hour ambulatory BP monitoring (ABPM) was performed before RDN and 6 months thereafter. BP variability was primarily assessed by means of standard deviation of 24-h systolic arterial BP (SD(sys)). Secondary measures of BP variability were maximum systolic BP (MAX(sys)) and maximum difference between two consecutive readings of systolic BP (Δmax(sys)) over 24 h. Six months after RDN, SD(sys), MAX(sys), and Δmax(sys) were significantly reduced from 16.9 ± 4.6 to 13.5 ± 2.5 mmHg (p = 0.003), from 190 ± 22 to 172 ± 20 mmHg (p < 0.001), and from 40 ± 15 to 28 ± 7 mmHg (p = 0.006), respectively, without changes in concomitant antihypertensive therapy. Reductions of SD(sys), MAX(sys), and Δmax(sys) were observed in 10/11 (90.9%), 11/11 (100%), and 9/11 (81.8%) patients, respectively. Although we noted a significant reduction of systolic office BP by 30.4 ± 27.7 mmHg (p = 0.007), there was only a trend in reduction of average systolic BP assessed from ABPM (149 ± 19 to 142 ± 18 mmHg; p = 0.086). CONCLUSION: In patients with therapy-refractory arterial hypertension, RDN leads to significant reductions of BP variability. Effects of RDN on BP variability over 24 h were more pronounced than on average levels of BP.
No takes yet. Share an insight, caveat, or question.
Zuern et al. (2012) conducted an observational in Therapy-refractory arterial hypertension (n=11). Renal sympathetic denervation vs. Baseline (before denervation) was evaluated on Standard deviation of 24-h systolic arterial BP (SDsys) (20.1% reduction, p=0.003). Renal sympathetic denervation reduced 24-hour systolic blood pressure variability (SDsys) by 20.1% at 6 months in patients with therapy-refractory arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: